This article reviews the published literature on the use of venlafaxine, fluoxetine, and paroxetine for the treatment of hot flashes.

Researchers have created an ultra-fast cancer treatment that can deliver much-needed treatment in just one second.

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the use case for the menopause treatment expected to launch as early as this ...

Announcing topline data from its OASIS 4 Phase 3 study, the German conglomerate said that its non-hormonal treatment option compared to placebo cut the occurrence of hot flashes (vasomotor symptoms) ...

Learn how this wearable technology helps women better understand and manage their menopause transition through real-time monitoring of hot flashes, sleep patterns and more.

Symptoms like insomnia, bloating and emotional shifts can occur before menopause begins, but they are often improperly ...

Hot flashes are most commonly caused by hormone changes related to menopause, Thurston explains. Specifically, the rapid ...

As Bayer awaits an FDA decision on its non-hormonal treatment for hot flashes caused by menopause, it's unveiling new results in a slightly different patient population: women whose hot flashes were ...

Menopause is a huge mental, emotional and physical change. Here's what you need to know about this stage of life, including ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Vasomotor symptoms are a common problem in women with HR-positive breast cancer receiving anti-cancer therapy.

Elinzanetant reduced vasomotor symptoms frequency and severity in women with or at high risk of HR-positive breast cancer in ...